YBX1 and colorectal carcinoma: Further qRT-PCR assays performed in training set and validation set samples revealed that only NSUN5 and YBX1 were enhanced in blood of CRC patients, whereas TET2 was not significantly altered (Figures 4C-E; Supplementary Figure 4A, B).